The CURE SYNGAP1 Grants Program funds research to advance clinical trial readiness and treatment development for SYNGAP1-Related Disorders.
Bayer funds educational projects to advance treatment strategies and clinical trial innovations in metastatic hormone-sensitive prostate cancer (mHSPC).
Biomarker Research Grant: Diagnostic and Prognostic Biomarker Development for Myasthenia Gravis and Related Neuromuscular Junction Disorders funds researchers developing biomarkers to improve diagnosis and prognosis.
PSC Partners Seeking a Cure's Research Grants Program supports investigators conducting basic and clinical research on PSC and closely associated diseases to advance treatments and a cure.
The PMSF Research Grants Program funds innovative basic and clinical research to advance understanding and treatment of Phelan-McDermid syndrome, supported by the Phelan-McDermid Syndrome Foundation.